" class="no-js "lang="en-US"> Blue Note Therapeutics - Medtech Alert
Sunday, August 31, 2025
Blue Note Therapeutics | Pharmtech Focus (2)

Blue Note Therapeutics

About Blue Note Therapeutics

Blue Note Therapeutics

Blue Note Therapeutics is a prescription digital therapeutics company singularly dedicated to serving patients suffering from cancer. We aim to make treatment accessible to any cancer patient, at any time, by merging deep scientific and clinical expertise, neuroscience, and digital innovation. Working closely with cancer research and patient communities, we are developing a pipeline of clinically validated prescription digital therapeutics to help reduce anxiety, depression, and other forms of cancer-related distress.

Related Story

Curebase and Blue Note Therapeutics Collaborate on Home-based Clinical Trial of Prescription Digital Therapeutics to Help People with Cancer Manage their Health

March 14 2022

Curebase, a company committed to democratizing access to clinical studies, and Blue Note Therapeutics, a prescription […]